The EMT-activator ZEB1 is unrelated to platinum drug resistance in ovarian cancer but is predictive of survival.

Hum Cell · 2022 · PMC9374625 · PMID 35794446

Europe PMC DOI

hedged sentence

0.0800

closest p · 1.6× alpha

0.0800

boldest claim

The sentences

approached significancep = 0.08so close (0.05 < p ≤ 0.1)

The knockdowns with ZEB1-1 and ZEB1-2 siRNA were significant knockdowns ( p = 0.04 and 8.0e−03, respectively), ZEB1-3 approached significance ( p = 0.08).

also in 8,237 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.